Raphael Pharmaceutical Inc.

RAPH · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$1,519-$1,344-$3,358-$1,624
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$390$200$2,290$0
Change in WC$597-$59$309$206
Other Non-Cash$0$0$0$0
Operating Cash Flow-$532-$1,203-$759-$1,418
Investing Activities
PP&E Inv.$0$0-$2$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$2$0
Financing Activities
Debt Repay.$41$0$0$174
Stock Issued$280$1,145$896$1,289
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$13
Financing Cash Flow$321$1,145$896$1,476
Forex Effect$0$0$0$0
Net Chg. in Cash-$211-$58$135$58
Supplemental Information
Beg. Cash$230$288$153$95
End Cash$19$230$288$153
Free Cash Flow-$532-$1,203-$761-$1,418